P Prahalathan1, S Kumar, B Raja. 1. Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar-608 002, Tamil Nadu, India.
Abstract
OBJECTIVE: To determine the protective effect of morin, a flavonoid against deoxycorticosterone acetate (DOCA)-salt induced hypertension in male Wistar rats. METHODS: Hypertension was induced in uninephrectomized rats by weekly twice subcutaneous injection of DOCA (25 mg/kg bw) and 1% NaCl in the drinking water for six consecutive weeks. Effect of morin against DOCA-salt induced hypertension was evaluated by measuring blood pressure and performing biochemical estimations and histopathological examination of renal tissues. RESULTS: DOCA-salt hypertensive rats showed considerably increased systolic and diastolic blood pressure, serum hepatic marker enzyme activities such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP) and gamma-glutamyl transpeptidase (GGT) and renal function markers (urea, uric acid and creatinine) in plasma. Oral administration of morin (25, 50 and 75 mg/kg bw) brought back all the above parameters to near normal level. Histopathology of kidney also confirmed the biochemical findings of this study. The effect at a dose of 50 mg/kg bw of morin was more pronounced than that of the other two doses (25 and 75 mg/kg bw). CONCLUSIONS: These findings indicate that morin exhibits strong antihypertensive effect against DOCA-salt induced hypertension.
OBJECTIVE: To determine the protective effect of morin, a flavonoid against deoxycorticosterone acetate (DOCA)-salt induced hypertension in male Wistar rats. METHODS:Hypertension was induced in uninephrectomized rats by weekly twice subcutaneous injection of DOCA (25 mg/kg bw) and 1% NaCl in the drinking water for six consecutive weeks. Effect of morin against DOCA-salt induced hypertension was evaluated by measuring blood pressure and performing biochemical estimations and histopathological examination of renal tissues. RESULTS:DOCA-salthypertensiverats showed considerably increased systolic and diastolic blood pressure, serum hepatic marker enzyme activities such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP) and gamma-glutamyl transpeptidase (GGT) and renal function markers (urea, uric acid and creatinine) in plasma. Oral administration of morin (25, 50 and 75 mg/kg bw) brought back all the above parameters to near normal level. Histopathology of kidney also confirmed the biochemical findings of this study. The effect at a dose of 50 mg/kg bw of morin was more pronounced than that of the other two doses (25 and 75 mg/kg bw). CONCLUSIONS: These findings indicate that morin exhibits strong antihypertensive effect against DOCA-salt induced hypertension.
Authors: Pamela J Mink; Carolyn G Scrafford; Leila M Barraj; Lisa Harnack; Ching-Ping Hong; Jennifer A Nettleton; David R Jacobs Journal: Am J Clin Nutr Date: 2007-03 Impact factor: 7.045
Authors: Mi K Kim; Hye S Jung; Chang S Yoon; Jeong H Ko; Hye J Chun; Tae K Kim; Min J Kwon; Soon H Lee; Kyung S Koh; Byung D Rhee; Jeong H Park Journal: Front Biosci (Elite Ed) Date: 2010-06-01
Authors: Fidèle Ntchapda; Christian Bonabe; Albert Donatien Atsamo; David Romain Kemeta Azambou; Yannick Bekono Fouda; Soudy Imar Djibrine; Paul F Seke Etet; Dimo Théophile Journal: Evid Based Complement Alternat Med Date: 2020-09-18 Impact factor: 2.629
Authors: Félix Vargas; Paola Romecín; Ana I García-Guillén; Rosemary Wangesteen; Pablo Vargas-Tendero; M Dolores Paredes; Noemí M Atucha; Joaquín García-Estañ Journal: Front Physiol Date: 2018-04-24 Impact factor: 4.566